DBV Technologies Added to Euronext Tech Leaders Index
Event summary
- DBV Technologies included in the Euronext Tech Leaders index effective June 22, 2026.
- Index highlights high-growth European tech and adjacent sectors like biotech and fintech.
- DBV focuses on VIASKIN® Peanut Patch for peanut allergy treatment in clinical trials.
- Company listed on Euronext Paris and Nasdaq Capital Market.
The big picture
DBV Technologies' inclusion in the Euronext Tech Leaders index underscores the growing recognition of European biotech innovators. The index, part of Euronext's initiative to spotlight high-growth tech companies, positions DBV alongside other sector leaders. This move could enhance visibility among institutional investors and accelerate DBV’s progress in developing non-invasive treatments for food allergies.
What we're watching
- Clinical Progress
- How the advancement of VIASKIN® Peanut Patch trials will impact DBV’s market position and investor confidence.
- Index Performance
- Whether inclusion in Euronext Tech Leaders index will drive increased institutional investment and liquidity.
- Regulatory Approvals
- The pace at which DBV can secure regulatory approvals for its product candidates, crucial for commercialization.